Vivus asks U.S. experts to back its obesity drug
(Reuters)
[unable to retrieve full-text content]Reuters - Proponents of a new obesity medication from Vivus Inc told U.S. reviewers on Wednesday that the drug's health benefits exceed heart and birth defect risks.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.